無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のインフルエンザワクチン市場・予測:規模・シェア・成長・動向予測

Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2024

発行 iGate Research Pvt Ltd 商品コード 396672
出版日 ページ情報 英文 224 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.77円で換算しております。
Back to Top
世界のインフルエンザワクチン市場・予測:規模・シェア・成長・動向予測 Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2024
出版日: 2018年07月12日 ページ情報: 英文 224 Pages
概要

当レポートでは、世界のインフルエンザワクチン市場について取り上げ、世界全体、地域、および国別による市場規模とそのシェア、接種者数とそのシェアの実績と予測を提供しており、ブランド別の売上・予測、市場影響因子の分析などをまとめ、お届けいたします。

第1章 エグゼクティブサマリー

第2章 世界:インフルエンザワクチン市場分析・予測

  • 世界:インフルエンザワクチン市場・予測
  • 世界:インフルエンザワクチン接種者数・予測

第3章 世界:インフルエンザワクチン市場分析・予測

  • インフルエンザワクチン市場シェア・予測:地域別分析
  • インフルエンザワクチン市場シェア・予測:国別分析
  • インフルエンザワクチン接種者数のシェア・予測:地域別分析
  • インフルエンザワクチン接種者数のシェア・予測:国別分析

第4章 インフルエンザワクチン市場、接種者数・予測:地域別

  • 北米
  • ラテンアメリカ
  • 欧州
  • アジア
  • オーストラレーシア

第5章 インフルエンザワクチン市場、接種者数・予測:国別

  • 米国
  • カナダ
  • ブラジル
  • メキシコ
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • 英国
  • オランダ
  • アイルランド
  • デンマーク
  • ルクセンブルク
  • スウェーデン
  • オーストラリア
  • ニュージーランド
  • 日本
  • 中国
  • インド
  • 韓国
  • タイ
  • シンガポール
  • 香港
  • マレーシア
  • インドネシア

第6章 世界:インフルエンザワクチンブランドの売上・予測

  • Fluarix / FluLaval の売上・予測
  • Fluzoneの売上・予測
  • Fluvirin/Flucelvax の売上・予測
  • Influvac (Abbottによる買収)の売上・予測
  • Afluria/Fluvax の売上・予測
  • FluMist/Fluenz の売上・予測
  • Flublokの売上・予測

第7章 インフルエンザワクチン市場:主要契約

  • M&A
  • ライセンシング合意

第8章 世界のインフルエンザワクチン市場:促進因子

  • ワクチン技術の転換
  • ワクチンは疾病を予防する最も費用対効果が高い手段
  • 化学的 & 技術的ブレークスルー
  • 引き続き効果的なコミュニケーション戦略の重視
  • 季節性インフルエンザ & ワクチンに対する認識の高まり

第9章 世界のインフルエンザワクチン市場:課題

  • ワクチン開発の複雑さおよび製品開発を妨げる認可システム
  • 認可ワクチンの最適な利用に対するハードル
  • ワクチン市場における新規参入者にとっての障壁
  • ワクチン開発スケジュールの短縮
  • 予防接種において医療従事者が直面する課題
目次

The global influenza vaccines market is anticipated to exceed US$ 5.8 Billion mark by 2024, and is presenting ample opportunities to the industry's players. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, introduction of new vaccines, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will drive the influenza vaccines market. However, shortage of vaccine supply due to genetic assortment of the viral strains is surging the need for updating vaccines each year by the manufacturers. This is a major factor restraining market growth.

Global Influenza Vaccines Market - Regional Analysis

  • Geographically, North America is the largest market for influenza vaccines capturing over 48% market share in 2017.
  • Asia is the second largest market for influenza vaccines.
  • Europe is the third largest market for influenza vaccines, followed by Latin America.
  • Australasia accounted for least share of the influenza vaccines market in 2017.

Global Influenza Vaccines Market - Country Wise Analysis

  • On the basis of country, United States captures majority of the influenza vaccines market.
  • Japan is the second largest market for influenza vaccines.
  • China, Brazil and India are the third, fourth and fifth leading market for influenza vaccines respectively.
  • Canada, Germany, France, UK, Italy, Spain and South Korea are the other leading market for influenza vaccines.

Global Influenza Vaccines Market - Brands Analysis

  • In the influenza vaccines brand sales segment, Sanofi's Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax.
  • In May 2016, the cell-based Flucelvax quadrivalent shot was approved by the FDA.
  • GSK's Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market.
  • Fluad is the first and only adjuvanted seasonal influenza vaccine in the US for adults aged 65 and older.
  • Flublok has captured least share of the influenza vaccines market.
  • In October 2016, Protein Sciences received approval from the FDA for the quadrivalent version of Flublok vaccine.
  • On August 28, 2017 - Sanofi announced that it has completed the acquisition of Protein Sciences.
  • In February 2018, SK Chemicals Co. signed a US$ 155 Million deal to license cell culture technology to Sanofi Pasteur Inc. for development of a universal influenza vaccine.

This is the 4th edition report on influenza vaccines market by iGATE Research. The report titled “Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis, Size, Share, Growth, Trends, Major Deals - Forecast to 2024” provides a comprehensive assessment of the fast-evolving, high-growth influenza vaccines market landscape.

This 224 Page report with 139 Figures and 12 Tables has been analyzed from 5 viewpoints:

  • 1. Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region (2011 - 2024)
  • 2. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2024)
  • 3. Global - Influenza Vaccines Brand Sales and Forecast to 2024
  • 4. Global Influenza Vaccines Market - Major Deals
  • 5. Global Influenza Vaccines Market - Driving Factors and Challenges

Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region

  • 1. North America
  • 2. Latin America
  • 3. Europe
  • 4. Asia
  • 5. Australasia

Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (25 Countries Covered)

  • 1. United States
  • 2. Canada
  • 3. Brazil
  • 4. Mexico
  • 5. Germany
  • 6. France
  • 7. Italy
  • 8. Spain
  • 9. United Kingdom
  • 10. Netherlands
  • 11. Ireland
  • 12. Denmark
  • 13. Luxembourg
  • 14. Sweden
  • 15. Australia
  • 16. New Zealand
  • 17. Japan
  • 18. China
  • 19. India
  • 20. South Korea
  • 21. Singapore
  • 22. Hong Kong
  • 23. Malaysia
  • 24. Thailand
  • 25. Indonesia

Influenza Vaccines Brand Sales and Forecast - 8 Brands Analyzed

  • 1. Fluarix/FluLaval
  • 2. Fluzone
  • 3. Fluvirin/Flucelvax
  • 4. Influvac
  • 5. Afluria/Fluvax
  • 6. FluMist/Fluenz
  • 7. Flublok
  • 8. Fluad

Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

  • Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
  • Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

1. Executive Summary

2. Global-Influenza Vaccines Market Analysis and Forecast (2011-2024)

  • 2.1. Global-Influenza Vaccines Market and Forecast (2011-2024)
  • 2.2. Global-Number of Persons Vaccinated with Influenza Vaccines and Forecast (2011-2024)

3. Global-Influenza Vaccines Market Share Analysis and Forecast

  • 3.1. Influenza Vaccines Market Share and Forecast-Region Wise Analysis (2011-2024)
  • 3.2. Influenza Vaccines Market Share and Forecast-Country Wise Analysis (2011-2024)
  • 3.3. Persons Being Vaccinated with Influenza Vaccines Share and Forecast-Region Wise Analysis (2011-2024)
  • 3.4. Persons Being Vaccinated with Influenza Vaccines Share and Forecast-Country Wise Analysis (2011-2024)

4. Influenza Vaccines Market, Persons Vaccinated and Forecast-By Region (2011-2024)

  • 4.1. North America-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.1.1. North America-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.1.2. North America-Influenza Vaccines Market and Forecast
  • 4.2. Latin America-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.2.1. Latin America-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.2.2. Latin America-Influenza Vaccines Market and Forecast
  • 4.3. Europe-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.3.1. Europe-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.3.2. Europe-Influenza Vaccines Market and Forecast
  • 4.4. Asia-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.4.1. Asia-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.4.2. Asia-Influenza Vaccines Market and Forecast
  • 4.5. Australasia-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.5.1. Australasia-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.5.2. Australasia-Influenza Vaccines Market and Forecast

5. Influenza Vaccines Market, Persons Vaccinated and Forecast-Country Wise Distribution (2011-2024)

  • 5.1. United States-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.1.1. United States-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.1.2. United States-Influenza Vaccines Market and Forecast
  • 5.2. Canada-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.2.1. Canada-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.2.2. Canada-Influenza Vaccines Market and Forecast
  • 5.3. Brazil-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.3.1. Brazil-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.3.2. Brazil-Influenza Vaccines Market and Forecast
  • 5.4. Mexico-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.4.1. Mexico-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.4.2. Mexico-Influenza Vaccines Market and Forecast
  • 5.5. Germany-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.5.1. Germany-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.5.2. Germany-Influenza Vaccines Market and Forecast
  • 5.6. France-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.6.1. France-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.6.2. France-Influenza Vaccines Market and Forecast
  • 5.7. Italy-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.7.1. Italy-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.7.2. Italy-Influenza Vaccines Market and Forecast
  • 5.8. Spain-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.8.1. Spain-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.8.2. Spain-Influenza Vaccines Market and Forecast
  • 5.9. United Kingdom-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.9.1. United Kingdom-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.9.2. United Kingdom-Influenza Vaccines Market and Forecast
  • 5.10. Netherlands-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.10.1. Netherlands-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.10.2. Netherlands-Influenza Vaccines Market and Forecast
  • 5.11. Ireland-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.11.1. Ireland-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.11.2. Ireland-Influenza Vaccines Market and Forecast
  • 5.12. Denmark-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.12.1. Denmark-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.12.2. Denmark-Influenza Vaccines Market and Forecast
  • 5.13. Luxembourg-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.13.1. Luxembourg-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.13.2. Luxembourg-Influenza Vaccines Market and Forecast
  • 5.14. Sweden-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.14.1. Sweden-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.14.2. Sweden-Influenza Vaccines Market and Forecast
  • 5.15. Australia-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.15.1. Australia-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.15.2. Australia-Influenza Vaccines Market and Forecast
  • 5.16. New Zealand-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.16.1. New Zealand-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.16.2. New Zealand-Influenza Vaccines Market and Forecast
  • 5.17. Japan-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.17.1. Japan-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.17.2. Japan-Influenza Vaccines Market and Forecast
  • 5.18. China-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.18.1. China-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.18.2. China-Influenza Vaccines Market and Forecast
  • 5.19. India-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.19.1. India-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.19.2. India-Influenza Vaccines Market and Forecast
  • 5.20. South Korea-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.20.1. South Korea-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.20.2. South Korea-Influenza Vaccines Market and Forecast
  • 5.21. Thailand-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.21.1. Thailand-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.21.2. Thailand-Influenza Vaccines Market and Forecast
  • 5.22. Singapore-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.22.1. Singapore-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.22.2. Singapore-Influenza Vaccines Market and Forecast
  • 5.23. Hong Kong-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.23.1. Hong Kong-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.23.2. Hong Kong-Influenza Vaccines Market and Forecast
  • 5.24. Malaysia-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.24.1. Malaysia-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.24.2. Malaysia-Influenza Vaccines Market and Forecast
  • 5.25. Indonesia-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.25.1. Indonesia-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.25.2. Indonesia-Influenza Vaccines Market and Forecast

6. Global-Influenza Vaccines Brand Sales and Forecast

  • 6.1. Global-Fluarix / FluLaval Sales and Forecast (2007-2024)
  • 6.2. Global-Fluzone Sales and Forecast (2009-2024)
  • 6.3. Global-Fluvirin/Flucelvax Sales and Forecast (2010-2024)
  • 6.4. Global-Influvac (Acquired by Abbott) Sales (2007-2009)
  • 6.5. Global-Afluria/Fluvax Sales and Forecast (2010-2024)
  • 6.6. Global-FluMist/Fluenz Sales and Forecast (2007-2024)
  • 6.7. Global-Flublok Sales and Forecast (2013-2024)
  • 6.8. Global-Fluad Sales and Forecast (2016-2024)

7. Influenza Vaccines Market-Major Deals

  • 7.1. Mergers and Acquisitions
  • 7.2. Licensing Agreements

8. Global Influenza Vaccines Market-Driving Factors

  • 8.1. Transformation of Vaccine Technologies
  • 8.2. Vaccines most Cost-Effective Means of Disease Prevention
  • 8.3. Scientific & Technological Breakthroughs
  • 8.4. Continuous Focus on Effective Communication Strategies
  • 8.5. Rising incidence of pandemic events Increasing Awareness on Seasonal Influenza & Vaccination

9. Global Influenza Vaccines Market-Challenges

  • 9.1. Complexity of Vaccine Development and Approval System Thwarts Product Development
    • 9.1.1. Legal Obstacles
    • 9.1.2. General Technical Barriers
    • 9.1.3. Economic Barriers
    • 9.1.4. Regulatory Barriers
  • 9.2. Hurdles to Optimal use of Licensed Vaccines
    • 9.2.1. Technical Obstacles
    • 9.2.2. Economic obstacles
    • 9.2.3. Cultural Obstacles
  • 9.3. Barriers to New Entrants in the Vaccines Market
  • 9.4. Reducing the Timeline for Vaccine Development
  • 9.5. Challenges Faced by Healthcare Workers in Immunization

List of Figures:

  • Figure 2-1: Global - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 2-2: Global - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 2-3: Global - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 2-4: Global - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 4-1: North America - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 4-2: North America - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 4-3: North America - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 4-4: North America - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 4-5: Latin America - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 4-6: Latin America - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 4-7: Latin America - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 4-8: Latin America - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 4-9: Europe - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 4-10: Europe - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 4-11: Europe - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 4-12: Europe - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 4-13: Asia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 4-14: Asia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 4-15: Asia - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 4-16: Asia - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 4-17: Australasia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 4-18: Australasia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 4-19: Australasia - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 4-20: Australasia - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-1: United States - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-2: United States - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-3: United States - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-4: United States - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-5: Canada - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-6: Canada - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-7: Canada - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-8: Canada - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-9: Brazil - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-10: Brazil - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-11: Brazil - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-12: Brazil - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-13: Mexico - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-14: Mexico - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-15: Mexico - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-16: Mexico - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-17: Germany - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-18: Germany - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-19: Germany - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-20: Germany - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-21: France - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-22: France - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-23: France - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-24: France - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-25: Italy - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-26: Italy - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-27: Italy - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-28: Italy - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-29: Spain - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-30: Spain - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-31: Spain - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-32: Spain - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-33: United Kingdom - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-34: United Kingdom - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-35: United Kingdom - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-36: United Kingdom - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-37: Netherlands - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-38: Netherlands - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-39: Netherlands - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-40: Netherlands - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-41: Ireland - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-42: Ireland - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-43: Ireland - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-44: Ireland - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-45: Denmark - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-46: Denmark - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-47: Denmark - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-48: Denmark - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-49: Luxembourg - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-50: Luxembourg - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-51: Luxembourg - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-52: Luxembourg - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-53: Sweden - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-54: Sweden - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-55: Sweden - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-56: Sweden - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-57: Australia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-58: Australia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-59: Australia - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-60: Australia - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-61: New Zealand - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-62: New Zealand - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-63: New Zealand - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-64: New Zealand - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-65: Japan - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-66: Japan - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-67: Japan - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-68: Japan - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-69: China - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-70: China - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-71: China - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-72: China - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-73: India - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-74: India - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-75: India - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-76: India - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-77: South Korea - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-78: South Korea - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-79: South Korea - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-80: South Korea - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-81: Thailand - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-82: Thailand - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-83: Thailand - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-84: Thailand - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-85: Singapore - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-86: Singapore - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-87: Singapore - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-88: Singapore - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-89: Hong Kong - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-90: Hong Kong - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-91: Hong Kong - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-92: Hong Kong - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-93: Malaysia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-94: Malaysia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-95: Malaysia - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-96: Malaysia - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 5-97: Indonesia - Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2017
  • Figure 5-98: Indonesia - Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2018 - 2024
  • Figure 5-99: Indonesia - Influenza Vaccines Market (Million US$), 2011 - 2017
  • Figure 5-100: Indonesia - Forecast for Influenza Vaccines Market (Million US$), 2018 - 2024
  • Figure 6-1: Global - Fluarix / Flulaval Influenza Vaccine Sales (Million US$), 2007 - 2017
  • Figure 6-2: Global - Forecast for Fluarix / Flulaval Influenza Vaccine Sales (Million US$), 2018 - 2024
  • Figure 6-3: Global - Fluzone Influenza Vaccine Sales (Million US$), 2009 - 2017
  • Figure 6-4: Global - Forecast for Fluzone Influenza Vaccine Sales (Million US$), 2018 - 2024
  • Figure 6-5: Global - Fluvirin/Flucelvax Influenza Vaccine Sales (Million US$), 2010 - 2017
  • Figure 6-6: Global - Forecast for Fluvirin/Flucelvax Influenza Vaccine Sales (Million US$), 2018 - 2024
  • Figure 6-7: Global - Influvac Influenza Vaccine Sales (Million US$), 2007 - 2009
  • Figure 6-8: Global - Afluria/Fluvax Influenza Vaccine Sales (Million US$), 2010 - 2017
  • Figure 6-9: Global - Forecast for Afluria/Fluvax Influenza Vaccine Sales (Million US$), 2018 - 2024
  • Figure 6-10: Global - FluMist/Fluenz Influenza Vaccine Sales (Million US$), 2007 - 2017
  • Figure 6-11: Global - Forecast for FluMist/Fluenz Influenza Vaccine Sales (Million US$), 2018 - 2024
  • Figure 6-12: Global - Flublok Influenza Vaccine Sales (Million US$), 2013 - 2017
  • Figure 6-13: Global - Forecast for Flublok Influenza Vaccine Sales (Million US$), 2018 - 2024
  • Figure 6-14: Global - Fluad Influenza Vaccine Sales (Million US$), 2016 - 2017
  • Figure 6-15: Global - Forecast for Fluad Influenza Vaccine Sales (Million US$), 2018 - 2024

List of Tables:

  • Table 3-1: Region Wise - Influenza Vaccines Market Share (Percent), 2011 - 2017
  • Table 3-2: Region Wise - Forecast for Influenza Vaccines Market Share (Percent), 2018 - 2024
  • Table 3-3: Country Wise - Influenza Vaccines Market Share (Percent), 2011 - 2017
  • Table 3-4: Country Wise - Forecast for Influenza Vaccines Market Share (Percent), 2018 - 2024
  • Table 3-5: Region Wise - Persons Vaccinated with Influenza Vaccines Share (Percent), 2011 - 2017
  • Table 3-6: Region Wise - Forecast for Persons Vaccinated with Influenza Vaccines Share (Percent), 2018 - 2024
  • Table 3-7: Country Wise - Persons Vaccinated with Influenza Vaccines Share (Percent), 2011 - 2017
  • Table 3-8: Country Wise - Forecast for Persons Vaccinated with Influenza Vaccines Share (Percent), 2018 - 2024
  • Table 7-1: Global - Mergers and Acquisitions in Influenza Vaccines Market (Million US$), 2005 - 2017
  • Table 7-2: Global - Licensing Agreement in Influenza Vaccines Market (Million US$), 2007 - 2018
  • Table 8-1: Improvement Strategies or Requirements - the Joint Commission and the Project's Collaborating Organizations
  • Table 8-2: Initiatives Taken in Communication, Education, Training & Information Exchange Related to Seasonal Influenza in European Countries, 2009
Back to Top